Search

Feb. 12 -- Hong Kong SAR Government issued the following Q&A: Following is a question by the Hon Judy Chan and a written reply by the Secretary for Health, Professor [...]

* Full-Year 2024 Revenues of $63.6 Billion, Reflecting 7% Year-over-Year Operational Growth ** Excluding Contributions from Paxlovid and Comirnaty(1), Revenues Grew 12% Operationally * Full-Year 2024 Reported(2) Diluted EPS of [...]

Washington: Salarius Pharmaceuticals, Inc., has filed FORM 8-K (Current Report) with the U.S. Securities and Exchange Commission on Jan 13, 2025: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 [...]

NEW YORK, NY -- The following information was released by Pfizer Inc.: Pfizer Inc. (NYSE:PFE) today provided its full-year 2025 guidance(1) and reaffirmed its October 29, 2024 full-year 2024 guidance(1) […]

The pandemic was a period we had never experienced before in our lifetimes, and hopefully never will again. People were forced to stay hunkered down in their homes. Many companies [...], However, don’t expect big immediate gains from Pfizer

Reuters - AstraZeneca overhauls management of its China division, FT reports - 18/1/2025 AstraZeneca has overhauled its local management in China, replacing Michael Lai with Alex Lin as the country's [...]

Bloomberg.com - Pfizer CEO Says Activist Wants Minimal Changes, Plays Down Fight - 14/1/2025 Pfizer Inc.'s dispute with activist firm Starboard Value LP isn't 'an aggressive situation,' Chief Executive Officer [...]

PharmaTimes - Amgen's lung cancer treatment gets conditional approval - 6/1/2025 The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has granted a conditional marketing authorisation for IMDYLLTRA (tarlatamab), a [...]

Reuters - Crunch week for UK's Thames Water as regulator rules, court process starts - 16/12/2024 Thames Water, the British utility that risks running out of cash, faces a crunch [...]

Reuters - GSK's drug combo shown to cut risk of death by 42% in type of blood cancer - 10/12/2024 British drugmaker GSK (GSK.L), opens new tab said on Monday [...]

Pharmaceutical Technology - Faron Pharma secures UK innovation passport for blood cancer immunotherapy - 2/12/2024 Faron Pharmaceuticals is advancing its cancer immunotherapy programme in the UK, with the region's regulatory [...]

London: UK Parliament has issued the following written answer: Answer Karin Smyth Answered on 19 November 2024 Decisions on whether licensed medicines should be recommended for routine National Health Service [...]

NEW YORK: PFIZER INC. has issued the following news release: Pfizer Inc. (NYSE: PFE) reported financial results for the third quarter of 2024 and raised its full-year 2024 guidance(1) for [...]

El tratamiento puede ayudar a evitar que los casos leves o moderados de covid se agraven. Esto es lo que hay que saber. https://whatsapp.com/channel/0029VaYKhdv5q08fphYVt40M La mayoría de los adultos en [...]

The treatment can help prevent mild or moderate cases of Covid-19 from becoming more severe. Here’s what to know. Most adults in the United States have one condition or another [...]

Byline: Mary Walrath-Holdridge, USA TODAY President Joe Biden has COVID-19 again and has been using Paxlovid, the Pfizer medication that has been widely used in the treatment of COVID symptoms [...]

Reuters - EU regulator backs Eisai-Biogen Alzheimer's drug after initial rejection - 15/11/2024 The European Union's drugs regulator on Thursday recommended approval of Eisai (4523.T), opens new tab and Biogen's [...]

Financial Times - AbbVie shares tumble after schizophrenia drug disappoints - 11/11/2024 Shares in AbbVie tumbled after the drugmaker revealed that an experimental treatment for schizophrenia, the main drug purchased [...]

Reuters - Bristol Myers earnings beat expectations, driven by sales of older drugs - 31/10/2024 Bristol Myers Squibb (BMY.N), opens new tab reported a higher-than-expected third-quarter profit on Thursday, citing [...]

Financial Times - Jeff Smith, the activist picking a fight with Covid hero Pfizer - 26/10/2024 Taking to the stage this week in front of an annual gathering of activist [...]

PMLiVE - Roche's Alecensa receives NICE recommendation to treat ALK-positive lung cancer - 21/10/2024 Roche's Alecensa (alectinib) has been recommended by the National Institute of Health and Care Excellence (NICE) [...]

China Daily - Global Edition - AstraZeneca expanding R&D pipeline in China - 14/10/2024 In an interview with China Daily, Sharon Barr, executive vice-president of biopharmaceuticals R&D at AstraZeneca, said [...]

China Daily - AstraZeneca announces plans for new innovations for China - 30/9/2024 United Kingdom-based biopharmaceutical giant AstraZeneca will add 10 to 15 new projects to the company's research and [...]

Financial Times - AstraZeneca drug fails to extend lives of breast cancer patients - 23/9/2024 Latest setback for Dato-DXd comes after disappointing results in lung cancer treatment earlier this month. [...]

Reuters - Sanofi, AstraZeneca win US approval for RSV therapy manufacturing line - 16/9/2024 Sanofi (SASY.PA), opens new tab and partner AstraZeneca (AZN.L), opens new tab have received approval from [...]

BioSpace - J&J Challenges AstraZeneca's Tagrisso With Phase III Data for Rybrevant, Lazcluze Combo - 9/9/2024 Johnson & Johnson on Sunday posted long-term follow-up data from the Phase III MARIPOSA [...]

Clinical Trials Arena - Bristol Myers Squibb's CAMZYOS offers benefits in oHCM trial - 2/9/2024 Bristol Myers Squibb (BMS) has unveiled new long-term follow-up results from the EXPLORER-LTE cohort of [...]

Company Reiterates Full-year Financial Guidance; On Track to Achieve Product Revenue Growth of at Least 10% vs. FY2023 Excluding Enzyme Sales Related to PAXLOVID(TM) Anticipate Entering First Technical Collaboration for [...]

LOS ANGELES, CA -- The following information was released by UCLA Health System: By Ask the Doctors Dear Doctors: Our dad is 77 years old and has diabetes. He got […]